IRIS
TARTAGLIONE, Immacolata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.186
NA - Nord America 1.829
AS - Asia 1.240
SA - Sud America 218
Continente sconosciuto - Info sul continente non disponibili 133
AF - Africa 28
OC - Oceania 2
Totale 6.636
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.130
US - Stati Uniti d'America 1.774
SG - Singapore 464
IT - Italia 369
IE - Irlanda 299
CN - Cina 254
HK - Hong Kong 212
BR - Brasile 179
VN - Vietnam 126
DE - Germania 105
GB - Regno Unito 91
KR - Corea 51
IN - India 35
JP - Giappone 32
UA - Ucraina 30
FR - Francia 29
CA - Canada 27
GR - Grecia 22
FI - Finlandia 20
AR - Argentina 17
AT - Austria 15
SE - Svezia 15
BD - Bangladesh 13
NL - Olanda 13
PK - Pakistan 13
MX - Messico 11
BE - Belgio 10
ZA - Sudafrica 10
TR - Turchia 9
CH - Svizzera 8
ES - Italia 8
VE - Venezuela 8
CR - Costa Rica 6
ID - Indonesia 6
JO - Giordania 6
EC - Ecuador 5
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
CL - Cile 3
MA - Marocco 3
PL - Polonia 3
RO - Romania 3
SV - El Salvador 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GT - Guatemala 2
IQ - Iraq 2
LT - Lituania 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TW - Taiwan 1
Totale 6.503
Salva come PNG Salva come JPEG
Città #
Moscow 785
Dublin 289
San Jose 239
Hong Kong 208
Singapore 207
Santa Clara 184
Ashburn 179
Chandler 122
Council Bluffs 106
Jacksonville 66
Beijing 51
Seoul 50
New York 45
Caserta 43
Milan 43
Princeton 43
Roxbury 38
Ann Arbor 36
Hanoi 35
Ho Chi Minh City 35
Naples 35
Bremen 33
Hefei 33
Munich 32
Dallas 27
Cambridge 21
Grumo Nevano 21
Los Angeles 21
Ercolano 20
Medford 20
Bengaluru 19
The Dalles 17
Wilmington 17
Woodbridge 17
Rome 16
São Paulo 14
Des Moines 13
Miano 12
Nuremberg 12
Da Nang 11
Helsinki 11
Nanjing 11
North Bergen 11
Boardman 10
Brussels 10
Vienna 10
London 9
Montreal 9
Amsterdam 8
Atlanta 8
Johannesburg 8
Napoli 8
Pozzuoli 8
Bologna 7
Brooklyn 7
Falkenstein 7
Haiphong 7
Phoenix 7
Redwood City 7
Belo Horizonte 6
Nanchang 6
Orem 6
Shanghai 6
Turku 6
Amman 5
Biên Hòa 5
Buffalo 5
Denver 5
Hillsboro 5
Orlando 5
Rio de Janeiro 5
Boston 4
Brasília 4
Campinas 4
Curitiba 4
Fairfield 4
Kochi 4
Lahore 4
Queens 4
Salvador 4
San Mateo 4
Stockholm 4
Taizhou 4
Tokyo 4
Toronto 4
Turin 4
Afragola 3
Aversa 3
Chicago 3
Guangzhou 3
Istanbul 3
Manchester 3
Mexico City 3
Philadelphia 3
Poplar 3
Quito 3
Ribeirão Preto 3
San Francisco 3
San José 3
San Salvador 3
Totale 3.545
Salva come PNG Salva come JPEG
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 234
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 222
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 185
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 183
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 180
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 173
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 171
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 167
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 165
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 162
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 158
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 158
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 152
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 152
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 149
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 147
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 147
Brain perfusion changes in beta-thalassemia 146
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 146
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 144
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 140
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 138
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 136
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 135
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 129
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 127
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 123
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 121
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 120
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 118
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 115
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 114
Hearing loss in beta-thalassemia: Systematic review 111
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 110
Cognitive impairment in hereditary spherocytosis 108
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 104
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 102
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 99
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 98
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 96
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 94
Pregnancy and childbirth in women with thalassemia: past and present 92
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 91
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 90
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 86
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 85
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 83
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 83
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 82
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 75
Disease Burden in Transfusion-Dependent β-Thalassemia (TDT) Patients and Caregivers in Italy: Results of a Cross-Sectional Descriptive Online Survey 28
International variations in body mass index within the CASiRe global cohort of sickle cell disease patients 23
Cerebrovascular involvement in hereditary spherocytosis: observational cohort and case-control MRI study 21
Identification of Novel Mutations in Patients Affected by Gaucher Disease 18
Totale 6.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.983
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022264 0 0 0 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025878 2 7 5 20 131 102 166 86 131 81 87 60
2025/20263.548 128 152 176 172 345 1.948 188 130 119 97 74 19
2026/2027633 17 111 189 316 0 0 0 0 0 0 0 0
Totale 6.636